BIOCON LTD Announces Quarterly Results (1QFY19); Net Profit Up 47.2%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD Announces Quarterly Results (1QFY19); Net Profit Up 47.2%
Mon, 30 Jul

BIOCON LTD has announced its results for the quarter ended June 2018. Here is a detailed performance review of the same:

BIOCON LTD Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-17*
3
Mar-18*
3
Jun-18*
QoQ ChangeYoY Change
Net SalesRs m9,33711,69511,238-3.9%20.4%
Other incomeRs m5406756881.9%27.4%
TurnoverRs m9,87712,37011,926-3.6%20.7%
ExpensesRs m7,4169,3658,860-5.4%19.5%
Gross profitRs m1,9212,3812,378-0.1%23.8%
DepreciationRs m9889539914.0%0.3%
InterestRs m1611691764.1%9.3%
Profit before taxRs m1,3121,9341,899-1.8%44.7%
TaxRs m37640752128.0%38.6%
Profit after taxRs m9361,5271,378-9.8%47.2%
Gross profit margin%20.620.421.2
Effective tax rate%28.721.027.4
Net profit margin%9.512.311.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 20.4% on a year-on-year (YoY) basis. The expenses were up by 19.5% YoY during the same period.
  • The company's operating profit increased by 23.8% YoY during the quarter. Consequently, operating profit margins remained same and stood at 21.2% in 1QFY19.
  • Depreciation charges and finance costs increased by 0.3% YoY and 9.3% YoY, respectively.
  • Other income increased by 27.4% YoY during the quarter.
  • Net profit for the quarter increased by 47.2% YoY. Net profit margins during the quarter increased from 9.5% in 1QFY18 to 11.6% in 1QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 3.9% on a quarter-on-quarter (QoQ) basis. The expenses were down by 5.4% QoQ during the same period.
  • The company's operating profit increased by 0.1% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 21.2% in 1QFY19 as against 20.4% in 4QFY18.
  • Net profit for the quarter declined by 9.8% QoQ, while net profit margins declined from 12.3% in 4QFY18 to 11.6% in 1QFY19.

To see how BIOCON LTD has performed over the last eight quarters, please visit here.

BIOCON LTD Share Price Performance

Over the last one year, BIOCON LTD share price has moved up from Rs 390.2 to Rs 581.2, registering a Gain of Rs 191.1 or around 49.0%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,122.7 (up 0.7%). Over the last one year it has moved down from 14,414.2 to 14,122.7, a gain of 291 points (down 2.0%).

Overall, the S&P BSE SENSEX is up 0.4% over the year.

Current Valuations

At the current price of Rs 581.2, the price to earnings (P/E) ratio of BIOCON LTD stands at 79.4 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 6.7 times.

Equitymaster requests your view! Post a comment on "BIOCON LTD Announces Quarterly Results (1QFY19); Net Profit Up 47.2%". Click here!

  

Related Views on News

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (1QFY20); Net Profit Down 11.5% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, BIOCON has posted a net profit of Rs 1 bn (down 11.5% YoY). Sales on the other hand came in at Rs 5 bn (down 57.2% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

How We Made 14.64% Trading Profit in Just 2 Days

Dec 12, 2019

A high probability trade that worked to perfection for my subscribers.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks(Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

What Is the IPO Euphoria Signaling Us About the Markets?(The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Dec 13, 2019 (Close)

TRACK BIOCON

BIOCON - TEVA PHARMA COMPARISON

COMPARE BIOCON WITH

MARKET STATS